Roivant Sciences Ltd. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Roivant Sciences Ltd. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Roivant Sciences Ltd. Operating Income (Loss) for the quarter ending September 30, 2024 was -$342M, a 59.8% decline year-over-year.
  • Roivant Sciences Ltd. Operating Income (Loss) for the twelve months ending September 30, 2024 was $4.27B.
  • Roivant Sciences Ltd. annual Operating Income (Loss) for 2023 was $4.24B.
  • Roivant Sciences Ltd. annual Operating Income (Loss) for 2022 was -$1.18B, a 13% increase from 2021.
  • Roivant Sciences Ltd. annual Operating Income (Loss) for 2021 was -$1.35B, a 26.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.24B +$5.42B Apr 1, 2023 Mar 31, 2024 10-K 2024-05-30
2022 -$1.18B +$176M +13% Apr 1, 2022 Mar 31, 2023 10-K 2024-05-30
2021 -$1.35B -$281M -26.2% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-28
2020 -$1.07B Apr 1, 2020 Mar 31, 2021 10-K 2022-06-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.